Porous polymeric support containing biological cells in interconnected voids

Claim 2

A process of preparing a compound comprising: (a) providing a biologically active system comprising biological cells and a solid support therefor, said support being formed of porous polyvinyl polymeric material having a porosity comprising voids and holes interconnecting said voids, said biologically active system being prepared by a process including the steps of: (i) preparing an emulsion having a continuous phase and an internal phase containing vinyl monomers and/or prepolymers, in which emulsion said monomers and/or prepolymers are present in the continuous phase of the emulsion, and said voids of said polymeric material being formed by the internal phase of the emulsion, (ii) polymerising said monomers and/or prepolymers in said continuous phase of said emulsion so as to form said polymeric material as a porous material having a total pore volume of at least 75% and having said porosity comprising said voids and holes, said voids having an average diameter within the range of from 1 to 150 μm, (iii) introducing biological cells into at least said voids of said polymeric material, said biological cells having a cell size such that the average size of said voids in said polymeric material is in the range 3 to 15 times said cell size of the biological cells, and the average size of said holes in said polymeric material is in the range 1 to 8 times the cell size of the biological cells, and (b) passing reactants into said voids via said interconnecting holes so as to contact said cells with said reactants, thereby causing said cells to produce said compound.

Claim 3

A process for preparing a biologically active system comprising biological cells and a solid support therefor, said support being formed of porous polyvinyl polymeric material having a porosity comprising voids and holes interconnecting said voids, said process including the steps of: (i) preparing an emulsion having a continuous phase and an internal phase containing vinyl monomers and/or prepolymers, in which emulsion said monomers and/or prepolymers are present in the continuous phase of the emulsion, and said voids of said polymeric material being formed by the internal phase of the emulsion, (ii) polymerising said monomers and/or prepolymers in said continuous phase of said emulsion so as to form said polymeric material as a porous material having a total pore volume of at least 75% and having said porosity comprising said voids and holes, said voids having an average diameter within the range of from 1 to 150 μm, and (iii) introducing biological cells into at least said voids of said polymeric material, said biological cells having a cell size such that the average size of said voids in said polymeric material is in the range 3 to 15 times said cell size of the biological cells, and the average size of said holes in said polymeric material is in the range 1 to 8 times the cell size of the biological cells.

Claim 4

A process for preparing a biologically active system comprising biological cells and a solid support therefor, said support being formed of porous polyvinyl polymeric material having a porosity comprising voids and holes interconnecting said voids, said process including the steps of: (i) preparing an emulsion having a continuous phase and an internal phase containing vinyl monomers and/or prepolymers, in which emulsion said monomers and/or prepolymers are present in the continuous phase of the emulsion, and said voids of said polymeric material being formed by the internal phase of the emulsion, (ii) polymerising said monomers and/or prepolymers in said continuous phase of said emulsion so as to form said polymeric material as a porous material having a total pore volume of at least 75% and having said porosity comprising said voids and holes, said voids having an average diameter within the range of from 1 to 150 μm, and (iii) introducing biological cells into at least said voids of said polymeric material, said biological cells having a cell size such that the average size of said voids in said polymeric material is in the range 3 to 15 times said cell size of the biological cells, and the average size of said holes in said polymeric material is in the range 1 to 8 times the cell size of the biological cells.

Claim 5

A process according to claim 2 wherein the emulsion is a water-in-oil emulsion having an aqueous phase and an oil phase, the monomers and/or prepolymers being in the oil phase.

Claim 6

A process according to claim 3 wherein the aqueous phase has an ionic strength of at least 10 -4 molar electrolyte.

Claim 7

A process according to claim 4 wherein the ionic strength of the aqueous phase is in the range from 10 -3 to 5 molar electrolyte.

Claim 8

A process according to claim 4 wherein the electrolyte is selected from the group comprising soluble halides and sulphates.

Claim 9

A process according to claim 2 including the step of washing the formed porous polymeric material prior to introducing the cells.

Claim 10

A process according to claim 2 wherein the polymeric porous material formed has a total pore volume of at least 90%.

Claim 11

A process according to claim 2 wherein the polymeric material is a cross-linked polymer.

Claim 12

A process according to claim 2 wherein on initial contact with the support the cells become localized within the support without covalent bonding.

Claim 13

A process according to claim 10 wherein on initial contact with the support the cells become localized within the support without either covalent or ionic bonding.

Claim 14

A process according to claim 2 wherein the cells become chemically bound to the material.

Claim 15

A process according to claim 2 wherein the cells are introduced into the support while in a growth-promoting medium.

Claim 16

A process according to claim 2 wherein the cells are selected from the group consisting of yeast cells, fungi, animal cells, plants cells and mixtures thereof.

Claim 17

A process according to claim 2 wherein the average size of said voids in the porous polymer material is in the range 6 to 12 times the cell size of the biological cells.

Claim 18

A process according to claim 2 wherein the average size of the holes is in the range 3 to 6 times the cell size.

Claim 19

A biologically active system prepared by a process according to claim 2.

Claim 20

A process for preparing a biologically active system comprising biological cells and a solid support for the cells, comprising the steps of preparing said support as a porous polyvinyl polymeric material having a porosity comprising voids and holes interconnecting said voids, said process including the steps of: (i) preparing an emulsion having a continuous phase and an internal phase containing vinyl monomers and/or prepolymers, in which emulsion said monomers and/or prepolymers are present in the continuous phase of the emulsion and the internal phase of the emulsion is at least 75% by volume, (ii) polymerising said monomers and/or prepolymers in said continuous phase of said emulsion so as to form said porous polymeric material as a material having a total pore volume of at least 75% and having said porosity comprising said voids and said holes, said voids being represented by the internal phase of the emulsion and having an average diameter within the range of from 1 to 150 μm, and (iii) thereafter introducing biological cells into a least said voids of said polymeric material while the cells are in a growth-promoting medium so that the cells initially become localized within the support without covalent bonding and subsequently adapt their morphology to form binding linkages to the support, said biological cells having a cell size such that the average size of said voids in said polymeric material is in the range 3 to 15 times said cell size of the biological cells, and the average size of said holes in said polymeric material is in the range 1 to 8 times the cell size of the biological cells.

Claim 21

A process for preparing a biologically active system comprising biological cells and a solid support for the cells, comprising the steps of preparing said support as a porous polyvinyl polymeric material having a porosity comprising voids and holes interconnecting said voids, said process including the steps of: (i) preparing an emulsion having a continuous phase and an internal phase containing vinyl monomers and/or prepolymers, in which emulsion said monomers and/or prepolymers are present in the continuous phase of the emulsion and the internal phase of the emulsion is at least 75% by volume, (ii) polymerising said monomers and/or prepolymers in said continuous phase of said emulsion so as to form said porous polymeric material as a material having a total pore volume of at least 75% and having said porosity comprising said voids and said holes, said voids being represented by the internal phase of the emulsion and having an average diameter within the range of from 1 to 150 μm, and (iii) thereafter introducing biological cells into a least said voids of said polymeric material while the cells are in a growth-promoting medium so that the cells initially become localized within the support without covalent bonding and subsequently adapt their morphology to form binding linkages to the support, said biological cells having a cell size such that the average size of said voids in said polymeric material is in the range 3 to 15 times said cell size of the biological cells, and the average size of said holes in said polymeric material is in the range 1 to 8 times the cell size of the biological cells.

Claim 22

A biologically active system prepared by a process according to claim 18.